U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. CPG Sec. 335.300 Hypnotherapy Devices - Self-Hypnotic Tape Recordings
  1. Search for FDA Guidance Documents

COMPLIANCE POLICY GUIDE (CPG)

CPG Sec. 335.300 Hypnotherapy Devices - Self-Hypnotic Tape Recordings January 1900

Download the Final Compliance Policy Guide (CPG)
Final
Docket Number:
FDA-2020-D-0957
Issued by:
Guidance Issuing Office
Office of Regulatory Affairs
Center for Devices and Radiological Health

This compliance policy guide provides guidance to FDA staff on the submission of regulatory action recommendations for self-hypnotic tape recordings which are misbranded.

Submit Comments

Submit Comments Online

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2020-D-0957.

Back to Top